Introducing i.Mune™ Tests
i.Mune™ TBNK [CE]
Relative and absolute quantification* of CD3+/CD4+/CD8+ T-, B- and NK lymphocytes from fresh blood
i.Mune™ NEO (in development)
Relative quantification of CD3+ T-, B- and NK lymphocytes, TSDR+ regulatory T cells (Treg) and neutrophils from dried blood spots (DBS).
(TSDR = Treg Specific De-methylated Region)
i.Mune™ PID (in development)
Relative and absolute quantification* of CD3+/CD4+/CD8+ T-, B-, NK cells, Treg, neutrophils and monocytes from dried blood spots (DBS) or fresh blood
*Relative quantification (%) is possible for all sample types; absolute quantification (cells/µl) currently for fresh blood, only
i.Mune™ is a registered trademark of Epimune GmbH, in Europe, USA and/or other selected countries, with trademarks pending in the US. All other trademarks, brands, names contained herein are the property of their respective owners.